NCT02010034View on ClinicalTrials.gov

Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

February 5, 2019

Study Completion Date

February 5, 2019

Conditions
Liver DiseaseImpaired Liver FunctionParenteral Nutrition Associated Liver Disease
Interventions
DRUG

Omegaven

Omegaven will be used in place of soy oil Intralipid

Trial Locations (1)

75235

Children's Medical Center of Dallas, Dallas

All Listed Sponsors
lead

Children's Medical Center Dallas

OTHER

NCT02010034 - Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury | Biotech Hunter | Biotech Hunter